Lauren Boebert suggests she had her third son because birth control was too expensive

Rep. Lauren Boebert revealed during a committee hearing Tuesday that she conceived her third son after failing to pick up her birth control because it was 'too expensive.' 

The House Oversight Committee hearing, focused on prescription drug prices, was targeting pharmacy benefit managers - middlemen who go between health insurance providers and prescription drug manufacturers. 

'I actually have a fun little story, my staff is probably going to talk to me about this later. But I left a prescription at a pharmacy once. I went to get birth control,' Boebert, R-Colo., shared during the hearing. 

Rep. Lauren Boebert revealed during a committee hearing Tuesday that she conceived her third son after failing to pick up her birth control because it was 'too expensive'

'I was there at the counter and went to pay for it. And the price was very, very high. I said, Wow, is this a three, six-month prescription? 'No, ma'am. This is one month.' And I said, it's cheaper to have a kid and I left it there and now I have my third son, Kaydon Boebert.' 

'And so I'm actually - it was, it turned out to be a really great thing, but I personally experience that when times were tough.'

Boebert's son Kaydon is 13 - she also has Tyler, 18, Brody, 16, and Roman, 10.

Earlier this year Boebert revealed her 18-year-old was set to be come a father as his girlfriend was pregnant.  

Boebert and her husband Jayson recently filed for divorce, with Boebert saying her husband 'never asked' to be in the spotlight. 

Without insurance, birth control pills can cost between $20 and $50 per month. With insurance costs can be as low as $0. 

There was bipartisan bashing of pharmacy benefit managers (PBMs) throughout the hearing. 

Lauren Boebert, pictured with her husband and four sons 

Boebert's third son, Kaydon, 13, was conceived because she couldn't afford birth control, she revealed Tuesday 

'List prices for prescription drugs have gone through the roof even though net prices have declined. And despite this increase in healthcare costs, life expectancy has remained stagnant. That means someone is benefitting, and it isn't patients. Look no further than PBMs, or pharmacy benefit managers,' Chair James Comer, R-Ky., said in opening remarks at the hearing. 

PBMs collect revenue both by collecting administrative and services fees and by collecting rebates from drug manufacturers. 

PBMs argue that they work for patients and manufacturers are to blame for high drug costs. They say that manufacturers post high list prices and patent protections restrict generic competition. 

The rebates PBMs get from drug companies are murky. Lawmakers on both sides of the aisle have called for legislation to increase oversight and transparency. 

Reigning in PBMs was initially suggested as part of the debt ceiling deal Speaker Kevin McCarthy and President Biden are hashing out, but that idea was suddenly taken off the table.  

Rep. Andy Biggs, R-Ariz., said PBMs 'should be outright eliminated. They are making billions in revenue at the expense of patients and taxpayers.' 

'As a cancer patient, recently declared in remission — I rang my bell three weeks ago … what you're telling me is just horrifying, the idea that you as the oncologist would prescribe a drug and be forced to use a different drug' due to PBMs, Rep. Jamie Raskin, D-Md., said.

'This committee tends to be a little partisan. I didn't know we could agree on much of anything. Today has revealed that miracles are still happening,' Rep. Jasmine Crockett, a Texas Democrat, added.